Miniaturising X-Ray
Peter Rowland – Managing Director – Micro-X Ltd is an award-winning ASX listed x-ray technology company.
Read MorePeter Rowland – Managing Director – Micro-X Ltd is an award-winning ASX listed x-ray technology company.
Read MoreBrent Barnes – CEO and Managing Director – LBT Innovations is a groundbreaking designer of advanced technology solutions for the medical industry.
Read MoreAdam Brimo – CEO – OpenLearning is revolutionising online learning to be a social and engaging experience.
Read MoreA keynote presentation on technology will be provided by Thomas Rice, Portfolio Manager for Perpetual Limited’s Global Innovation Share Fund.
Read MoreThe S&P 500 index lost 0.8% and the Nasdaq index fell by 133 points or 0.9%. Over the week, the Dow fell 2.2%; the S&P 500 fell 1.7%; and the Nasdaq lost 1.6%.
Read MoreThe Australian sharemarket edged higher on Friday thanks to gains across most sectors. Unfortunately this follows the largest tumble in six and a half months on Thursday, dragging the ASX 200 lower this week.
Read MoreThe Australian sharemarket is up ~0.3% at midday after posting its biggest tumble in 6 1/2 months on Thursday. The ASX 200 is being led higher by mining stocks.
Read MoreThe Dow Jones index dropped by 152 points or 0.4%. The S&P 500 index lost 0.5% and the Nasdaq index fell by 38 points or 0.3%.
Read MoreThe Australian sharemarket slumped by 1.9% on Thursday; its worst decline in months. Every sector and ~95% of stocks finished in the red.
Read MoreThe Australian sharemarket is down by more than 1% at midday, with banks and miners weighing most heavily on the ASX 200.
Read MoreUS and European equity markets traded lower overnight as investors look ahead for the next significant catalyst. US sharemarkets retreated on Wednesday as investors reassessed valuations amid rising economic risks.
Read MoreAussie shares ended lower for the first time since last Thursday with the ASX 200 dropping 18 points or 0.25% to 7,512. Mining, IT & consumer staples weighed most while financials lead the improvements.
Read MoreThe Aussie market has again opened lower but is attempting a slight revival around lunch. The ASX 200 is down 24 points or 0.3% approaching midday with selling across most sectors.
Read MoreUS and European stocks generally trended lower over the course of the session overnight as investors considered the prospect of moderating growth as long term interest rates edged higher.
Read MoreThe Aussie market managed to rally late to finish flat for the day. The ASX 200 added just 1.8pts to 7,530 with miners weighing on the market.
Read MoreThe Aussie market is in the red by ~0.5% at lunch on Tuesday. Heavyweight miners are a major weight with the iron ore price tumbling 9% overnight while banks are also weaker ahead of the RBA September interest rate decision at 2.30pm AEST.
Read MoreOver the week, the Dow fell by 0.2%, the S&P 500 rose by 0.6% and the Nasdaq gained 1.6%.
Read MoreThe Australian sharemarket is sliding on Monday, with losses across most sectors at midday. Fortescue Metals is the main weight as it trades ex-dividend for its largest ever distribution to investors next month.
Read MoreCatch up on the full webinar with presentations from Cynata Therapeutics (ASX: CYP), Atomo Diagnostics (ASX: AT1), NeuroScientific (ASX: NSB) & Kazia Therapeutics (ASX: KZA).
Read MoreDr Ross Macdonald – Managing Director and Chief Executive Officer – Cynata Therapeutics Limited is an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology.
Read MoreJames Garner – Managing Director & CEO – Kazia Therapeutics Limited is an innovative oncology-focused biotechnology company. Kazia is working to develop therapies across a range of oncology indications.
Read MoreDougal Thring – VP Clinical Development – NeuroScientific Biopharmaceuticals is developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet medical needs.
Read MoreJohn Kelly – Founder, Managing Director & CEO – Atomo Diagnostics Limited is a global leader in the design of medical devices for blood-based rapid testing for professional use and self-testing.
Read MoreTech stocks rose but bank stocks fell. The Dow Jones index fell by 75 points or 0.2%.
Read MoreThe Dow Jones index rose by 131 points or 0.4%. The S&P 500 index added 0.3% to a record high. And the Nasdaq index rose by 22 points or 0.1% to a record high.
Read MorePart Six of Six in a video series with Schroders Australia Fund Manager Simon Adler, in which he tells us how Schroders’ Global Recovery Fund has outperformance of the MSCI World index.
Read MoreThe Aussie market has continued its weaker start to September with the ASX 200 falling a second successive session. The benchmark index lost 41pts or 0.55% to 7,485.
Read MoreThe ASX 200 is down 75pts ~1% near lunch on Thursday as it continues a weak start to September. The market is predominantly being weighed down by heavyweight names trading ex-dividend.
Read MoreTechnology shares outperformed as traders turned defensive on concerns about a potential slowing in job hiring. Apple (+0.5%) shares hit all-time highs. And shares of Netflix (+2.3%), Amazon (+0.2%) and Google-owner Alphabet (+0.4%) all advanced.
Read MoreThe Australian sharemarket eased by 0.1% on Wednesday, bouncing off this morning’s low thanks to better than expected GDP, together with gains from offshore markets.
Read MoreThe Dow Jones index fell by 39 points or 0.1%. The S&P 500 index fell 0.1% from record highs. And the Nasdaq index lost 7 points or less than 0.1%.
Read MorePengana Fund manager James McDonald provides insight into why he believes biotech Immutep is very well placed to benefit from the current environment and how it fits in the portfolio structure.
Read MoreAussie shares ended August with a solid performance. The ASX 200 added 30 points or 0.4% to 7,535 and rising 1.9% for the month. It is now 11 consecutive monthly gains for the Aussie market, the best run since 1943.
Read MoreThe ASX 200 is slightly higher at lunch on Tuesday with gains led by IT & healthcare offsetting energy and financial losses. Harvey Norman (HVN) lifted its FY21 profit by 75% but its shares are down with lockdowns impacting its July /Aug trading.
Read MoreA video investor update from ASX-listed, Canadian-based manganese producer Euro Manganese.
Read MoreThe Dow Jones index fell by 56 points or 0.2%. The S&P 500 index gained 0.4% to record highs. And the Nasdaq index lifted by 136 points or 0.9% to a new record high.
Read MoreThe Aussie market managed a slight improvement to start the week with the ASX 200 lifting 16 points or 0.22% to 7,504.5 on Monday. Materials were the standout in what was a mostly underwhelming session for the market.
Read MoreThe Australian sharemarket is off to a shaky start on Monday, with losses across most sectors being offset by surging mining stocks.
Read MoreCatch up on the full webinar with presentations from Golden Mile Resources (ASX: G88), Miramar Resources (ASX: M2R), Empire Energy (ASX: EEG) & Krakatoa Resources (ASX: KTA)
Read MoreColin Locke – Executive Chairman – Krakatoa Resources Limited is committed to the acquisition and value addition of mineral and energy projects with a focus on high value metals.
Read More